Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew A Menza

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Essential Psychopharmacology|July 27, 2005
The management of fatigue in depressed patientsHumberto Marin, Matthew A Menza
Psychiatry (Edgmont (Pa. : Township))|January 4, 2011
Specific treatment of residual fatigue in depressed patientsHumberto Marin, Matthew A Menza
European Psychiatry : the Journal of the Association of European Psychiatrists|June 8, 2002
Modafinil monotherapy in depressionKenneth R Kaufman, Matthew A Menza, Adriana Fitzsimmons
Journal of Clinical Psychopharmacology|April 7, 2007
An open-label trial of aripiprazole augmentation for treatment-resistant generalized anxiety disorderMatthew A Menza, Roseanne D Dobkin, Humberto Marin
The Journal of Clinical Psychiatry|November 25, 2003
Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled studyCharles DeBattista, Karl Doghramji, Matthew A Menza, et al.
Journal of Geriatric Psychiatry and Neurology|June 28, 2018
Personalized Telemedicine for Depression in Parkinson's Disease: A Pilot TrialRoseanne D Dobkin, Alejandro Interian, John Logan Durland, et al.
CNS Spectrums|December 28, 2018
Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensusKevin J Black, Henry Nasrallah, Stuart Isaacson, et al.
CNS Spectrums|June 12, 2019
Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensusKevin J Black, Henry Nasrallah, Stuart Isaacson, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Essential Psychopharmacology|July 27, 2005
The management of fatigue in depressed patientsHumberto Marin, Matthew A Menza
Psychiatry (Edgmont (Pa. : Township))|January 4, 2011
Specific treatment of residual fatigue in depressed patientsHumberto Marin, Matthew A Menza
European Psychiatry : the Journal of the Association of European Psychiatrists|June 8, 2002
Modafinil monotherapy in depressionKenneth R Kaufman, Matthew A Menza, Adriana Fitzsimmons
Journal of Clinical Psychopharmacology|April 7, 2007
An open-label trial of aripiprazole augmentation for treatment-resistant generalized anxiety disorderMatthew A Menza, Roseanne D Dobkin, Humberto Marin
The Journal of Clinical Psychiatry|November 25, 2003
Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled studyCharles DeBattista, Karl Doghramji, Matthew A Menza, et al.
Journal of Geriatric Psychiatry and Neurology|June 28, 2018
Personalized Telemedicine for Depression in Parkinson's Disease: A Pilot TrialRoseanne D Dobkin, Alejandro Interian, John Logan Durland, et al.
CNS Spectrums|December 28, 2018
Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensusKevin J Black, Henry Nasrallah, Stuart Isaacson, et al.
CNS Spectrums|June 12, 2019
Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensusKevin J Black, Henry Nasrallah, Stuart Isaacson, et al.
Pageof 1